ApexPeptides

Growth-Hormone & Body-Composition Research

Ipamorelin 10mg

Ipamorelin 10mg

Ipamorelin 10mg

A focused lens on selective GH-release signalling.

A selective ghrelin-receptor agonist studied for controlled growth-hormone release and secretagogue pharmacology.

Documentation
Check batch record
Availability
In stock
IDR 1.999.000
View COAPublished records onlyLot match requiredSecure checkout

For qualified laboratory research only · Not for human or veterinary use

Why researchers choose it

Ipamorelin activates the growth-hormone secretagogue receptor. Early human pharmacology recorded a discrete, dose-linked GH response, making the molecule relevant to selective secretagogue research.

Research focus

  • Ghrelin-receptor agonism
  • Selective growth-hormone release
  • Secretagogue PK and PD research

Evidence snapshot

Early human studies support short-term pharmacodynamic GH release, not physique, strength, fat-loss or recovery outcomes. Product-specific human safety is not established.

Best suited to

For controlled secretagogue and endocrine-response research with defined sampling windows.

Research focus describes published study domains, not a guaranteed outcome. No human or veterinary dosing, reconstitution or administration instructions are supplied.

Related research compounds

CJC-1295 + DACGH & Body Composition

A long-acting GHRH analogue studied for sustained growth-hormone and IGF-1 signalling in endocrine research.

In stock
Per vialIDR 1.399.000
TesamorelinGH & Body Composition

A GHRF analogue studied across growth-hormone signalling, IGF-1 response and visceral-adipose biology.

In stock
Per vialIDR 2.999.000